The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx

Cancer

Volumn 115, Issue 24, 2009, Pages 5723-5733

  Zafereo, Mark E ^a   Hanasono, Matthew M ^b   Rosenthal, David I ^b   Sturgis, Erich M ^b   Lewin, Jan S ^b   Roberts, Diana B ^b   Weber, Randal S ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Complications; Cost; Functional outcomes; Head and neck cancer; Oropharynx; Recurrent squamous cell carcinoma; Salvage surgery; Speech; Survival; Swallowing

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SPEECH INTELLIGIBILITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TRACHEOTOMY; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 73149090130     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24595     Document Type: Article

References (35)

1. Goodwin WJ. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000;110(suppl 93):1-18.
2. Jesse RH, Sugarbaker EV. Squamous cell carcinoma of the oropharynx: why we fail. Am J Surg. 1976;132:504-507.
3. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys. 1996;34:289-296.
4. Chen AY, Schrag N, Hao Y, Stewart A, Ward E. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope. 2007;117:16-21.
5. Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol. 1974;6:357-380.
6. Pradhan SA, Rajpal RM, Kothary PM. Surgical management of postradiation residual/recurrent cancer of the base of the tongue. J Surg Oncol. 1980;14:201-206.
7. Gehanno P, Depondt J, Guedon C, et al. Primary and salvage surgery for cancer of the tonsillar region: a retrospective study of 120 patients. Head Neck. 1993;15:185-189.
8. Wong LY, Wei WI, Lam LK, Yuen APO. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25:953-959.
9. De Crevoisier R, Bourhis J, Domenge C, et al. Fulldose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 1998;16:3556-3562.
10. De Crevoisier R, Domenge C, Wibault P, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer. 2001;91:2071-2076.
11. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2001;51:1299-1304.
12. Warren S, Gates O. Multiple primary malignant tumors. A survey of the literature and statistical study. Am J Cancer. 1932;16:1358-1414.
13. Greene FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
14. Urken ML, Buchbinder D, Constantino PD, et al. Oromandibular reconstruction using microvascular composite flaps: report of 210 cases. Arch Otolaryngol Head Neck Surg. 1998;124:46-55.
15. Kim AJ, Suh JD, Sercarz JA, et al. Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope. 2007;117:1019-1023.
16. Garofalo MC, Haraf DJ. Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol. 2002;14:330-333.
17. Spencer SA, Harris J, Wheeler RH, et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck. 2008;30:281-288.
18. Langer CJ, Harris J, Horwitz EM, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with splitcourse concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007;25:4800-4805.
19. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol. 1992;10:1245-1251.
20. Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116-1127.
21. Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer. 2000;36:1032-1037.
22. Stell PM. Survival times in end-stage head and neck cancer. Eur J Surg Oncol. 1989;15:407-410.
23. Stell PM. Time to recurrence of squamous cell carcinoma of the head and neck. Head Neck. 1991;13:277-281.
24. Agra IMG, Carvalho AL, Ulbrich FS, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck. 2006;28:107-113.
25. Llewelyn J, Mitchell R. Survival of patients who needed salvage surgery for recurrence after radiotherapy for oral carcinoma. Br J Oral Maxillofac Surg. 1997;35:424-428.
26. Lacy PD, Spitznagel EL, Piccirillo JF. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma. Cancer. 1999;86:1387-1395.
27. Agra IMG, Carcalho AL, Pinto CAL, et al. Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg. 2008;134:743-749.
28. Agra IMG, Carvalho AL, Pontes E, et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003;129:1317-1321.
29. Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an international American Head and Neck Society member survey. Head and Neck. 2005;27:952-928.
30. Zbaren P, Nuyens M, Curschmann J, Stauffer E. Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas. Head Neck. 2007;29:26-32.
31. Arnold DJ, Goodwin J, Weed DT, Civantos FJ. Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck. Semin Radiat Oncol. 2004;14:190-195.
32. Lavertu PL, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124:401-406.
33. Netscher DT, Meade RA, Goodman CM, Alford EL, Stewart MG. Quality of life and disease-specific functional status following microvascular reconstruction for advanced (T3 and T4) oropharyngeal cancers. Plast Reconstr Surg. 2000;105:1628-1634.
34. Schechter CB. Cost effectiveness in context. J Clin Oncol. 2007;25:609-610.
35. Fryback DG, Craig BM. Measuring economic outcomes of cancer. J Natl Cancer Inst Monogr. 2004;33:134-141.